Losing Weight and Triglycerides: A Case of Tirzepatide Use in a Patient with Familial Chylomicronemia Syndrome

Presented by: Linda Liu, M.D.

Learning Objectives:

1. Describe familial chylomicronemia syndrome (FCS) diagnosis, pathophysiology, and management.
2. Identify notable considerations in weight loss management for patients with lipid disorder.
3. Discuss use of tirzepatide and other GLP1 receptor agonists in patients with lipid disorders.

AND

“Obesity, Hypertension, and Kidney Disease.”

Presented by:  Silvana Pannain, M.D.

Learning Objectives:

1. Case-Based Understanding of Obesity Pathophysiology: Gain an in-depth understanding of the underlying pathophysiology of the relationship between obesity, HTN and Kidney disease through the analysis and discussion of clinical cases.
2. Enhance participants' knowledge in iatrogenic weight gain in HTN and the effect of weight loss in HTN and Kidney disease.
3. Enhance participants' knowledge and skills in the utilization of antiobesity medications in HTN and Kidney disease.